tweenvest

Nordicus Partners Corporation (NasdaqCM: NORD)

Health Care · Biotechnology · US

$2.70

-9.70% today · -46.0% 1Y

Public summary
A free snapshot of Nordicus Partners Corporation, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Nordicus Partners Corporation (NasdaqCM: NORD) operates in the Biotechnology industry within the Health Care sector. The company is valued at $52.66M and employs 15 people.

Over the last twelve months the share price has lost 46.0%, trading between 1.48 and 5.15.

Tweenvest scores Nordicus Partners Corporation across four factors: quality 25/100, value 43/100. Its strongest factor is value.

NORD price history

Nov 21, 2025 · 4.80Weekly closes 2.04 – 5.05Nov 12, 2026 · 2.70

Key figures

Market cap
$52.66M
Revenue (TTM)
—
P/E
-10.38
EPS
-0.29
Dividend yield
—
Beta (5Y)
-0.63
52-week high
$5.15
52-week low
$1.48
Avg volume (3M)
—
Shares outstanding
19.50M
Employees
15
Next earnings
—

About Nordicus Partners Corporation

Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.

ISIN
US28265K3041
Founded
1993
Listed since
Jun 12, 1996
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Synthaverse S.A.WSE: SVE$53.98Mzł2.84+7.17%
Amicogen, Inc.KOSDAQ: A092040$53.39M₩1,013.00+1.30%
Xilio Therapeutics, Inc.NasdaqCM: XLO$53.26M$7.54-2.08%
Nuo Therapeutics, Inc.OTCPK: AURX$52.79M$1.09+1.87%
UBI Pharma Inc.UNQ: 6562$52.10MNT$14.25+1.79%
Libo Pharma Corp.TPEX: 7888$52.06MNT$22.80-1.51%
BIO-FD&C Co.,Ltd.KOSDAQ: A251120$51.71M₩7,950.00-10.17%
3D Global Biotech Inc.TPEX: 6808$51.68MNT$25.50-0.78%

Browse every Biotechnology company →